![Matthew Calistri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Calistri
Investor Relations Contact at
CEREVEL THERAPEUTICS HOLDINGS, INC.
Profile
Matthew Calistri is currently Senior Director-Investor Relations at Biogen Idec, Inc. (North Carolina), Managing Director at Bain Capital Life Sciences LP since 2024, and Head-Investor Relations at Cerevel Therapeutics Holdings, Inc. Formerly, Mr. Calistri worked as Investor Contact at Biogen, Inc. Education includes an undergraduate degree from Fordham University conferred in 1992 and an MBA from The University of Chicago Booth School of Business conferred in 1999.
Matthew Calistri active positions
| Companies | Position | Start |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Investor Relations Contact | - |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Investor Relations Contact | - |
Bain Capital Life Sciences LP
 Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Private Equity Investor | 01/09/2024 |
Former positions of Matthew Calistri
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Public Communications Contact | 01/06/2019 |
Training of Matthew Calistri
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
97
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Finance |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
- Stock Market
- Insiders
- Matthew Calistri
